HK42696A - Use of 2-amino-2,4,4-trimethylpentane salt of clavulanic acid in producing pharmaceutically acceptable salts of clavulanic acid - Google Patents

Use of 2-amino-2,4,4-trimethylpentane salt of clavulanic acid in producing pharmaceutically acceptable salts of clavulanic acid Download PDF

Info

Publication number
HK42696A
HK42696A HK42696A HK42696A HK42696A HK 42696 A HK42696 A HK 42696A HK 42696 A HK42696 A HK 42696A HK 42696 A HK42696 A HK 42696A HK 42696 A HK42696 A HK 42696A
Authority
HK
Hong Kong
Prior art keywords
clavulanic acid
amino
pharmaceutically acceptable
acceptable salts
producing pharmaceutically
Prior art date
Application number
HK42696A
Other languages
English (en)
Inventor
Krenmueller Franz
Summer Harald
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of HK42696A publication Critical patent/HK42696A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
HK42696A 1992-03-10 1996-03-14 Use of 2-amino-2,4,4-trimethylpentane salt of clavulanic acid in producing pharmaceutically acceptable salts of clavulanic acid HK42696A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0047292A AT400033B (de) 1992-03-10 1992-03-10 Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben

Publications (1)

Publication Number Publication Date
HK42696A true HK42696A (en) 1996-03-22

Family

ID=3491521

Family Applications (1)

Application Number Title Priority Date Filing Date
HK42696A HK42696A (en) 1992-03-10 1996-03-14 Use of 2-amino-2,4,4-trimethylpentane salt of clavulanic acid in producing pharmaceutically acceptable salts of clavulanic acid

Country Status (21)

Country Link
US (4) US20010036940A1 (sv)
JP (2) JP2817563B2 (sv)
CN (3) CN1045604C (sv)
AT (1) AT400033B (sv)
AU (1) AU659282B2 (sv)
CH (1) CH685054A5 (sv)
CY (1) CY1995A (sv)
DE (1) DE4307422B4 (sv)
DK (1) DK26093A (sv)
ES (1) ES2058029B1 (sv)
FI (1) FI101965B (sv)
FR (1) FR2688506B1 (sv)
GB (1) GB2264944B (sv)
GR (1) GR1002329B (sv)
HK (1) HK42696A (sv)
IE (1) IE70926B1 (sv)
IT (1) IT1261213B (sv)
NL (1) NL9300430A (sv)
NO (1) NO301372B1 (sv)
SE (1) SE508043C2 (sv)
TW (1) TW364907B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT399155B (de) * 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
SI9300296B (sl) * 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
KR100200239B1 (ko) * 1992-10-21 1999-06-15 김충환 클라불란산 칼륨염의 제조방법
DE69427312T2 (de) 1993-11-17 2001-08-23 Biochemie Ges.M.B.H., Kundl Trennung von Cephalosporinisomeren
GB9426261D0 (en) 1994-12-24 1995-02-22 Spurcourt Ltd Clavulanic acid salts
DE69618045D1 (de) * 1995-02-25 2002-01-31 Spurcourt Ltd Clavulansäure Salz
KR100200242B1 (ko) * 1995-05-16 1999-06-15 김충환 클라불란산염의 제조 방법
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
CN1312814A (zh) * 1998-07-16 2001-09-12 Dsm公司 制备棒酸盐类及其酯类的改进方法
MXPA01009808A (es) * 1999-04-01 2002-04-24 Dsm Nv Aglomerados por cristalizacion.
IL152643A0 (en) * 2000-05-13 2003-06-24 Smithkline Beecham Plc Process for the purification of a salt of clavulanic acid
KR101772375B1 (ko) * 2005-09-07 2017-08-29 신라젠(주) Gm-csf를 발현하는 폭스바이러스를 사용한 전이성 및/또는 전신 파종성 암의 전신 치료법
JP7028064B2 (ja) 2018-05-30 2022-03-02 横河電機株式会社 機器保全装置、機器保全方法、機器保全プログラム及び記録媒体
JP2023533544A (ja) 2020-07-10 2023-08-03 カーボン クリーン ソリューションズ リミテッド 低位熱を使用して溶媒から二酸化炭素を除去するための方法およびシステム

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3288800A (en) 1962-05-29 1966-11-29 Squibb & Sons Inc Schiff's bases of 6-amino-penicillanic acid and purification of 6-aminopenicillanic acid by the use thereof
GB1508977A (en) 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
NZ177159A (en) 1974-04-20 1978-03-06 Beecham Group Ltd Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions
US4110165A (en) 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
US4144242A (en) 1975-02-07 1979-03-13 Glaxo Laboratories Limited Process for the purification of clavulanic acid
GB1543563A (en) 1975-02-07 1979-04-04 Glaxo Lab Ltd Beta-lactam antibiotic in purified form
GB1561395A (en) 1976-02-26 1980-02-20 Beecham Group Ltd -lactam antibiotic
GB1578739A (en) * 1976-07-23 1980-11-05 Beecham Group Ltd Amine salts of clavulanic acid methods for their preparation and compositions containing them
GB2003863B (en) 1977-09-01 1982-03-31 Beecham Group Ltd Chemical process
EP0002312B1 (en) 1977-11-26 1982-02-03 Beecham Group Plc Derivatives of clavulanic acid and pharmaceutical compositions containing them
BE862211A (fr) * 1977-12-22 1978-06-22 Beecham Group Ltd Agents antibacteriens
DE3063683D1 (en) 1979-08-24 1983-07-14 Beecham Group Plc Amine salt of clavulanic acid, its preparation and use
US4454069A (en) 1979-08-24 1984-06-12 Beecham Group Limited Clavulanic acid salts and their preparation from the tertiary butyl amine salt
MX7417E (es) 1984-10-27 1988-10-14 Antibioticos Sa Metodo para la preparacion de acido clavulanico y sus derivados
GB8618888D0 (en) 1986-08-01 1986-09-10 Davy Mckee Ltd Process
US5679789A (en) 1987-01-29 1997-10-21 Beecham Group, P.L.C. Pharmaceutical compositions comprising potassium clavulanate and methods of using them
ES2008418A6 (es) 1987-01-29 1989-07-16 Beecham Group Plc Un procedimiento para la obtencioon de nueva forma cristalina del clavulanato de potasio y de composiciones del mismo.
ES2010143A6 (es) * 1989-03-01 1989-10-16 Pharma Mar S A Pharmar Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp.
US5210296A (en) 1990-11-19 1993-05-11 E. I. Du Pont De Nemours And Company Recovery of lactate esters and lactic acid from fermentation broth
AT399155B (de) 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
SI9300296B (sl) 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
SI9200139A (en) 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
KR100200239B1 (ko) 1992-10-21 1999-06-15 김충환 클라불란산 칼륨염의 제조방법
GB9401969D0 (en) 1994-02-02 1994-03-30 Smithkline Beecham Plc Process
SI9400107A (en) 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
DE69618045D1 (de) 1995-02-25 2002-01-31 Spurcourt Ltd Clavulansäure Salz
GB2298201B (en) 1995-02-25 1997-05-28 Spurcourt Ltd Clavulanic acid salts
SI9500074A (en) 1995-03-10 1996-10-31 Lek Tovarna Farmacevtskih Process for preparation of alkani salts of clavulanic acid.
SI9500134B (sl) 1995-04-20 2004-04-30 Lek, Postopek za pripravo čistih alkalijskih soli klavulanske kisline
KR100200242B1 (ko) 1995-05-16 1999-06-15 김충환 클라불란산염의 제조 방법
GB9515809D0 (en) 1995-08-02 1995-10-04 Smithkline Beecham Plc Process
SI9500265A1 (en) 1995-08-28 1997-02-28 Lek Tovarna Farmacevtskih Process for purification of the aqueous fermented broth filtrate of streptomyces sp. p 6621 ferm p 2804 by ultrafiltration
ZA975198B (en) 1996-06-13 1997-12-15 Smithkline Beecham Corp Improved process for preparing potassium clavulanate.
PL333247A1 (en) 1996-11-11 1999-11-22 Gist Brocades Bv Method of manufacturing of salts and esters of clavulan acid

Also Published As

Publication number Publication date
USH2158H1 (en) 2006-06-06
GB9304704D0 (en) 1993-04-28
US20010036940A1 (en) 2001-11-01
JPH0641143A (ja) 1994-02-15
IE70926B1 (en) 1997-01-15
DK26093D0 (da) 1993-03-09
ITRM930147A1 (it) 1994-09-10
CN1079743A (zh) 1993-12-22
NL9300430A (nl) 1993-10-01
ES2058029A1 (es) 1994-10-16
DE4307422A1 (de) 1993-09-30
SE9300758D0 (sv) 1993-03-08
DK26093A (da) 1993-09-11
DE4307422B4 (de) 2004-11-25
ES2058029B1 (es) 1995-05-01
AU659282B2 (en) 1995-05-11
CN1145906A (zh) 1997-03-26
GR1002329B (el) 1996-05-15
JPH1067785A (ja) 1998-03-10
US20030203886A1 (en) 2003-10-30
CN1150153A (zh) 1997-05-21
GR930100090A (el) 1993-11-30
US20030022882A1 (en) 2003-01-30
CN1045604C (zh) 1999-10-13
FI931032A0 (fi) 1993-03-09
NO301372B1 (no) 1997-10-20
FR2688506B1 (fr) 1995-06-23
SE508043C2 (sv) 1998-08-17
CH685054A5 (de) 1995-03-15
AT400033B (de) 1995-09-25
GB2264944B (en) 1995-09-06
IE930172A1 (en) 1993-09-22
ITRM930147A0 (it) 1993-03-10
NO930829D0 (no) 1993-03-08
FI931032L (fi) 1993-09-11
ATA47292A (de) 1995-01-15
NO930829L (no) 1993-09-13
CY1995A (en) 1997-09-05
AU3407093A (en) 1993-09-16
FI101965B1 (sv) 1998-09-30
GB2264944A (en) 1993-09-15
FR2688506A1 (fr) 1993-09-17
TW364907B (en) 1999-07-21
JP2817563B2 (ja) 1998-10-30
US20020072513A1 (en) 2002-06-13
SE9300758L (sv) 1993-09-11
IT1261213B (it) 1996-05-09
FI101965B (sv) 1998-09-30

Similar Documents

Publication Publication Date Title
HUT69374A (en) Novel process for the preparation of clavulanic acid, its pharmaceutically salts and esters
CA2046998A1 (en) Method of producing liposomal products
HK42696A (en) Use of 2-amino-2,4,4-trimethylpentane salt of clavulanic acid in producing pharmaceutically acceptable salts of clavulanic acid
AU8180487A (en) 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same
AU3954589A (en) The production of formate salts of nitrogenous bases
AU3266189A (en) Pyridone carboxylic acid derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same
ES2042534T3 (es) Un proceso para la preparacion de una preparacion topica en forma de un hidrogel.
NO301767B1 (no) Salt av clavulansyre
AU6740296A (en) Process for the preparation of potassium clavulanate
HUT71793A (en) 2,4-diamino-3-hydroxy-carboxylic acid derivatives, pharmaceutical compns. contg. them and process for producing the said compds.
AU9004591A (en) 1,4-benzothiazine-2-acetic acid derivatives, processes for production thereof
IE813100L (en) Naphthyridine derivatives
IE810808L (en) Isophthalic acid picolylamide monohydrate
IE810311L (en) Guanylamidines.
HUT50476A (en) Process for producing 3-pyrrolidinyl-thio-1-azabicyclo/3,2,0/hept-2-ene-2-carboxylic acid derivatives
RU93004798A (ru) Новые азетидиновые производные пиридонкарбоновых кислот, способ их получения, фармацевтическая композиция на их основе и использование
AU5823294A (en) 1,4-benzoxazine-2-acetic acid compound, process for producing the same, and use thereof
AU1016288A (en) 2,1-benzothiazepine-2,2-dioxide-5-carboxylic acid derivatives
EP0552019A3 (en) Method of producing 1,4-dihydroxy-2-naphthoic acid
AU7729691A (en) Carbamic acid derivatives, and their production and use
GR3021347T3 (en) Diamine salts of clavulanic acid.
SI0711350T1 (en) Clavulanic acid dehydrogenase, preparation and use for the production of clavulanic acid
IL111317A (en) Process for preparing N-(2,6-dichloro-3-methylphenyl)-5,7-dihalo¬1,2,4¾-triazolo¬1,5-a¾pyrimidine-2-sulfonamide by cyclization of the corresponding 5-amino¬1,2,4¾triazole-3-sulfonamide with malonic acid and halo-dehydroxylation of the product
HU914020D0 (en) Process for the production of d1, d, and 1/1,2,3,4/tetrahydro-izokynoline-1-carbonic acid and its uretane type derivatives with n-protection group
AU619124C (en) Salts of N5,N10-methylene-5,6,7,8-tetrahydrofolic acid

Legal Events

Date Code Title Description
PF Patent in force
AS Change of ownership

Owner name: SANDOZ AG

Free format text: FORMER OWNER(S): SANDOZ GMBH

CHPA Change of a particular in the register (except of change of ownership)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100308